Monday, 16 April 2012

Preventing and treating bacterial infections...

University of Edinburgh researchers have developed a family of peptide mimetics, that are completely resistant to host protease degradation. In both in vitro and in vivo models of infection they show highly efficient entry into eukaryotic cells, without host toxicity, and confer effective antimicrobial killing.

A non‐toxic cell penetrating peptide mimetic with potent antimicrobial activity against clinically important multi‐drug resistant human pathogens has been designed and evaluated by the team. This novel anti-infective has particular utility for the  treatment of intracellular infections and clearance of nonreplicating bacteria impervious to currently available therapeutic regimes.